Last update: June 3, 2021
The 340B program is administered by the Health Resources & Services Administration (HRSA).
Pharmaceutical companies participating in Medicaid programs are required to adhere to Section 340B of the Public Health Service Act. It allows them to sell outpatient drugs at discounted prices to eligible covered entities, making them affordable for many uninsured and low-income patients.
Follow these guidelines when filing billing claims:
For more information, go to 340B Drug Pricing Program | Official website of the U.S. Health Resources & Services Administration (hrsa.gov).